COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1481: Articles 14801-14810  | Next

Double-stranded RNA drives SARS-CoV-2 nucleocapsid protein to undergo phase separation at specific temperatures
Roden, C., Dai, Y., Seim, I., Lee, M., Sealfon, R., McLaughlin, G., Boerneke, M., Iserman, C., Wey, S. A., Ekena, J. L., Troyanskaya, O. G., Weeks, K., You, L., Chilkoti, A., Gladfelter, A.
10.1101/2021.06.14.448452 — Posted: 2021-06-15
Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19
Bohan, D., Van Ert, H., Ruggio, N., Rogers, K. J., Baddredine, M., Briseno, J. A. A., Rojas Chavez, R. A., Gao, B., Stokowy, T., Christakou, E., Micklem, D., Gausdal, G., Haim, H., Minna, J., Lorens, J. B., Maury, W.
10.1101/2021.06.15.448419 — Posted: 2021-06-15
Increased sensitivity of SARS-CoV-2 to type III interferon in human intestinal epithelial cells
Kee, C., Metz-Zumaran, C., Doldan, P., Guo, C., Stanifer, M., Boulant, S.
10.1101/2021.06.14.448464 — Posted: 2021-06-15
Proinflammatory responses in SARS-CoV-2 infected and soluble spike glycoprotein S1 subunit activated human macrophages
Chiok, K., Hutchison, K., Miller, L. G., Bose, S., Miura, T. A.
10.1101/2021.06.14.448426 — Posted: 2021-06-15
Multi-Dimensional Reduction Clustering of Complex Carbohydrates Reveal Tissue Metabolism, Heterogeneity and Histopathology
Conroy, L. R., Allison, D. B., Sun, Q., Young, L. E., Hawkinson, T. R., Clarke, H. A., Ferreira, J. E., Hammonds, A. V., McDonald, R. J., Absher, K. J., Alilain, W. J., Waters, C. M., Liu, J., Sun, R. C.
10.1101/2021.06.14.448358 — Posted: 2021-06-15
MMMVI: Detecting SARS-CoV-2 Variants of Concern in Metagenomic Samples
Barker, D. O. R., Buchanan, C. J., Landgraff, C., Taboada, E. N.
10.1101/2021.06.14.448421 — Posted: 2021-06-15
Stepwise evolution and exceptional conservation of ORF1a/b overlap in coronaviruses
Mei, H., Nekrutenko, A.
10.1101/2021.06.14.448413 — Posted: 2021-06-15
Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants
Glebov, O. O.
10.1101/2021.06.15.448391 — Posted: 2021-06-15
The SARS-CoV-2 nucleocapsid protein associates with the replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress
Scherer, K. M., Mascheroni, L., Carnell, G. W., Wunderlich, L. C. S., Makarchuk, S., Brockhoff, M., Mela, I., Fernandez-Villegas, A., Barysevich, M., Stewart, H., Suau Sans, M., George, C. L., Lamb, J. R., Kaminski Schierle, G. S., Heeney, J. L., Kaminski, C. F.
10.1101/2021.06.15.448497 — Posted: 2021-06-15
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
Tostanoski, L., Gralinski, L., Martinez, D., Schaefer, A., Mahrokhian, S., Li, Z., Nampanya, F., Wan, H., Yu, J., Chang, A., Liu, J., McMahan, K., Dinnon, K., Leist, S. R., Baric, R. S., Barouch, D. H.
10.1101/2021.06.14.448461 — Posted: 2021-06-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).